pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,151 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
  • phase 1 initiation
39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06912659: The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

    Sponsor: Boehringer Ingelheim. Phase: . Conditions: Pulmonary Fibrosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05462262: Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population

    Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: NA. Conditions: Coronary Artery Disease Progression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06001346: CBT+ for Depression

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469488: A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

    Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE4. Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors, Infusion Reaction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07245888: ClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia

    Sponsor: Region Skane. Phase: . Conditions: Ventilator Acquired Pneumonia, Mechanical Ventilation Complication

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03211988: Entinostat Neuroendocrine (NE) Tumor

    Sponsor: Antonio Fojo. Phase: PHASE2. Conditions: Neuroendocrine Tumors

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05083403: HPI (Hypotension Prediction Index) Care Trial

    Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Cardiopulmonary Bypass Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06033027: Arm Use With Soft-robotic Glove

    Sponsor: Roessingh Research and Development. Phase: NA. Conditions: Trauma Injury of Hand Multiple, Neurologic Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02897427: Throat and Other HPV-Related Cancers in Men: Identifying Them Early

    Sponsor: Baylor College of Medicine. Phase: . Conditions: Human Papillomavirus Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07413627: A Study Evaluating the Contribution of Non-Coplanar Beam Arrangement in Reducing Toxicity in Radiotherapy for Upper Aerodigestive Tract Cancers

    Sponsor: Centre Georges Francois Leclerc. Phase: NA. Conditions: Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06070961: Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

    Sponsor: Fondazione Italiana Linfomi - ETS. Phase: . Conditions: Follicular Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05933161: A Study of Glycemic Control in Left Ventricular Assist

    Sponsor: Mayo Clinic. Phase: . Conditions: Type 2 Diabetes Mellitus, Hyperglycemia, Hypoglycemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06008561: Midwest Birth Outcomes and Indigenous American Pregnancy

    Sponsor: Sanford Health. Phase: . Conditions: Pregnancy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04491942: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Gastric Carcinoma, Advanced Head and Neck Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Penile Carcinoma, Advanced Pleural Malignant Mesothelioma, Advanced Urothelial Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Distal Bile Duct Cancer AJCC v8, Stage III Intrahepatic Bile Duct Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Penile Cancer AJCC v8, Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Distal Bile Duct Cancer AJCC v8, Stage IV Intrahepatic Bile Duct Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Penile Cancer AJCC v8, Stage IV Pleural Diffuse Malignant Mesothelioma AJCC v8, Triple-Negative Breast Carcinoma, Unresectable Urothelial Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06565442: Feasibility of Using NeuraSignal Transcranial Doppler Robot

    Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Cerebral Autoregulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542886: A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults

    Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07227870: L19IL2/TNF in Patients With Basal Cell Carcinoma

    Sponsor: Philogen S.p.A.. Phase: PHASE2. Conditions: Locally Advanced Basal Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07696273: Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia

    Sponsor: Indiana University. Phase: NA. Conditions: Diabetes, Hyperglycemia, Hypoglycemia (Diabetic)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07648173: Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improve Health

    Sponsor: William Carey University. Phase: NA. Conditions: Spinal Cord Injuries

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT02702869: Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)

    Sponsor: Duke University. Phase: . Conditions: Cleft Lip, Cleft Palate, Cleft Lip and Palate

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05999773: SGLT-2 Inhibitors in the Treatment of Ascites

    Sponsor: University of Palermo. Phase: . Conditions: Ascites Hepatic, Cirrhosis, Liver, Diabete Type 2

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05388669: A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Advanced or Metastatic Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07071883: Group Activities to Support Addiction Recovery

    Sponsor: University of Nebraska. Phase: NA. Conditions: Addiction, Substance Use Disorders (SUD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07638241: Agentic AI Personalized Dietary Management Study

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07653841: Perturbation Based Balance Training Versus Progressive Neuromuscular Training as an Adjunct to Conventional Physiotherapy for Pain Reduction and Functional Improvement in Knee Osteoarthritis

    Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05144854: A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

    Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Gastric Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07356141: Monitoring Occupational Dental Stress Using Apple Watch

    Sponsor: University of Illinois at Chicago. Phase: . Conditions: Occupational Stress

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07662005: Objective Sleep Characteristics and Neoadjuvant Immunotherapy Response in Gastric/GEJ Cancer

    Sponsor: West China Second University Hospital. Phase: . Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Sleep, Pathological Response

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05460494: Reduce Loneliness in Care Partners of Persons With AD/ADRD

    Sponsor: Northwell Health. Phase: NA. Conditions: Loneliness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05733494: Cross Cultural Validation of the Italian Version of the Clinical Assessment of Dysphagia in Neurodegeneration

    Sponsor: Istituti Clinici Scientifici Maugeri SpA. Phase: . Conditions: Swallowing Disorder, Dysphagia, Neuro-Degenerative Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05807594: Healthy Mom Zone Gestational Weight Gain Management Intervention 2.0

    Sponsor: Penn State University. Phase: NA. Conditions: Gestational Weight Gain, Overweight and Obesity, Pregnancy, Energy Balance

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05301894: Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

    Sponsor: Neurocrine Biosciences. Phase: PHASE2. Conditions: Epileptic Encephalopathy, Continuous Spike and Wave During Sleep

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06548594: Out of State - tAN hEDS

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Hypermobile EDS (hEDS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07175194: Association Between EIT and CT During PEEP Titration in Patients With Acute Respiratory Failure

    Sponsor: Istituto Clinico Humanitas. Phase: . Conditions: Acute Hypoxemic Respiratory Failure, Ventilation, Mechanical

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06245122: A Study of CS23546 in Subjects With Advanced Tumors

    Sponsor: Chipscreen Biosciences, Ltd.. Phase: PHASE1. Conditions: Advanced Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06961851: Feasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)

    Sponsor: University of Minnesota. Phase: EARLY_PHASE1. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07333222: Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis

    Sponsor: Somogy Megyei Kaposi Mór Teaching Hospital. Phase: NA. Conditions: Stroke, Multiple Sclerosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07303322: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)

    Sponsor: Eurofarma Laboratorios S.A.. Phase: PHASE3. Conditions: Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07678229: BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

    Sponsor: Rong Tao. Phase: PHASE3. Conditions: Extranodal NK/T-cell Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07282002: Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis

    Sponsor: Angiodynamics, Inc.. Phase: NA. Conditions: Infective Endocarditis (IE)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05060302: Prognosis of Right Ventricular Dysfunction Assessed by Speckle Tracking in Postoperative Thoracic Surgery

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Right Ventricle, Thoracic Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05737602: Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Von Hippel-Lindau Disease, Genetic Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07400237: Laparoscopic Ultrasound Versus Fluorescence Cholangiography in Technically Challenging Laparoscopic Cholecystectomy

    Sponsor: Consorci Sanitari Integral. Phase: NA. Conditions: Cholecystectomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04026503: Live Long Walk Strong (LLWS) Rehabilitation Program: What Features Improve Mobility Skills

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Mobility Limitation

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06419127: Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing

    Sponsor: Gattaca Genomics. Phase: . Conditions: Infertility, Female, Infertility, Male, Infertility, IVF, Aneuploidy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07585227: Study of the Effects of Acute Exposure to Moderate Altitude Hypoxia on Prospective Memory.

    Sponsor: Direction Centrale du Service de Santé des Armées. Phase: NA. Conditions: Hypoxia, Hypoxia Brain, Hypoxia Altitude Simulation Test, Hypoxia in Healthy Individuals, Hypoxia, Altitude, Hypoxia, Brain, Altitude, Altitude Hypoxia, Normobaric Hypoxia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07679061: First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)

    Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Unresectable Hepatocellular Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02744261: Developing Rectal USPE Measures for Suppositories (Project DRUM-S)

    Sponsor: The Miriam Hospital. Phase: NA. Conditions: Microbicide Delivery System Perceptibility and Acceptability

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02090361: Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Skin Graft, Collagen -Elastin Matrix

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02712086: Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery

    Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Obesity

    full page →ctgov ↗
    ← prev
    page 85 of 104
    next →